<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Human Genetics and Genomics</title>
<title_fa>Journal of Human Genetics and Genomics</title_fa>
<short_title>jhgg</short_title>
<subject>Medical Sciences</subject>
<web_url>http://humangeneticsgenomics.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2588-6479</journal_id_issn>
<journal_id_issn_online>2588-6479</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.61882/jhgg</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1402</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2023</year>
	<month>5</month>
	<day>1</day>
</pubdate>
<volume>7</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>New Perspective on the Action Mechanism of Doxorubicin in Breast Cancer- Overexpressions of miR-874-3p and miR-337-3p and Downregulation of STAT3 Gene</title>
	<subject_fa>تخصصي</subject_fa>
	<subject>Gene expression</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div&gt;
&lt;table align=&quot;left&quot; hspace=&quot;0&quot; vspace=&quot;0&quot;&gt;
	&lt;tbody&gt;
		&lt;tr&gt;
			&lt;td style=&quot;padding: 0in 12px; text-align: justify;&quot; valign=&quot;top&quot;&gt;&lt;span style=&quot;font-size:14px;&quot;&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;font-family:Calibri,sans-serif&quot;&gt;&lt;b&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;font-family:CapitoliumNewsW01-2Regular&quot;&gt;Background: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;font-family:CapitoliumNewsW01-2Regular&quot;&gt;Breast cancer is one of the common malignancies in women, for which doxorubicin (DOX) is widely used in its chemotherapy. Recently, it has been found that DOX affects the expression profile of oncogene genes and miRNAs. In this study, the impacts of DOX on the expressions of the STAT3 gene, miR-874-3p, and miR-337-3p were studied in the MCF-7 breast cancer cell line.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
			&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;font-family:Calibri,sans-serif&quot;&gt;&lt;b&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;font-family:CapitoliumNewsW01-2Regular&quot;&gt;Methods&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;font-family:CapitoliumNewsW01-2Regular&quot;&gt;: After exposure of MCF-7 cells with DOX, the MTT method was applied for evaluating the cell viability. Apoptosis and necrosis percentages were measured using flow cytometry. Also, the levels of ROS and NF-&lt;/span&gt;&lt;span cambria=&quot;&quot; style=&quot;font-family:&quot;&gt;&amp;kappa;&lt;/span&gt;&lt;span style=&quot;font-family:CapitoliumNewsW01-2Regular&quot;&gt;B were measured in DOX-treated cells. Then, exosomes secreted from these cells were prepared. The shape of exosomes was studied by SEM. Finally, the expression of bax, bcl-2, p53, casp3, STAT3 gene, and miR-874-3p and miR-337-3p in MCF-7 cells as well as exosomes were evaluated using the RT-PCR technique. Data analysis was done by T-test in GraphPad Prism8 software.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
			&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;font-family:Calibri,sans-serif&quot;&gt;&lt;b&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;font-family:CapitoliumNewsW01-2Regular&quot;&gt;Results&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;font-family:CapitoliumNewsW01-2Regular&quot;&gt;: The exposure of MCF-7 cells to doxorubicin led to a concentration-dependent decrease in cell viability and increases in apoptosis and necrosis. ROS and NF-&lt;/span&gt;&lt;span cambria=&quot;&quot; style=&quot;font-family:&quot;&gt;&amp;kappa;&lt;/span&gt;&lt;span style=&quot;font-family:CapitoliumNewsW01-2Regular&quot;&gt;B activity were increased in DOX-treated cells. In DOX-treated cells, decreased expressions of bcl-2 and STAT3 genes and overexpression of bax, p53, casp3, miR-874-3p, and miR-337-3p were observed compared to untreated control cells.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
			&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;font-family:Calibri,sans-serif&quot;&gt;&lt;b&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;font-family:CapitoliumNewsW01-2Regular&quot;&gt;Conclusion&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;line-height:115%&quot;&gt;&lt;span style=&quot;font-family:CapitoliumNewsW01-2Regular&quot;&gt;: One of the mechanisms of the anti-breast cancer effects of DOX is the induction of changes in the expression of oncogenic genes, mediating by downregulating of STAT3 gene and overexpressing miR-874-3p and miR-337-3p. More studies are needed in this field.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
		&lt;/tr&gt;
	&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Breast cancer, Gene, miRNA, Doxorubicin</keyword>
	<start_page>0</start_page>
	<end_page>0</end_page>
	<web_url>http://humangeneticsgenomics.ir/browse.php?a_code=A-10-370-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Siroos</first_name>
	<middle_name></middle_name>
	<last_name>Tarighi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>siroosta2@gmail.com</email>
	<code>1003194753284600749</code>
	<orcid>0009-0001-5228-6085</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Cellular and molecular biology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Maryam</first_name>
	<middle_name></middle_name>
	<last_name>Montazeri</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>m.montazeri2023@gmail.com</email>
	<code>1003194753284600750</code>
	<orcid>1003194753284600750</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Medical Biotechnology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Fatemeh</first_name>
	<middle_name></middle_name>
	<last_name>Rohollah</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>panirohollah@yahoo.com</email>
	<code>1003194753284600751</code>
	<orcid>1003194753284600751</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Cellular and molecular biology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
